Last quarter (Q ), RespireRx Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q, RespireRx Pharmaceuticals's net income was $-691.79K. See RespireRx Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	-	$ 332.51K	$ 0.00	$ 0.00	$ 0.00
Cost of Revenue	$ -339.60K	$ -339.60K	$ -448.63K	-	-	-
Gross Profit	$ 339.60K	$ 339.60K	$ 448.63K	-	-	-
Operating Expense	$ 3.40M	$ 1.58M	$ 2.56M	$ 3.32M	$ 1.74M	$ 2.18M
Operating Income	$ -685.41K	$ -1.58M	$ -2.56M	$ -3.32M	$ -1.74M	$ -2.18M
Net Non Operating Interest Income Expense	$ -456.97K	$ -603.82K	$ -724.77K	$ -545.67K	$ -404.66K	$ -136.24K
Other Income Expense	$ -79.10K	$ -28.84K	$ -62.55K	$ -440.40K	$ 26.13K	$ -279.02K
Pretax Income	$ -1.09M	$ -2.10M	$ -3.15M	$ -4.30M	$ -2.12M	$ -2.59M
Tax Provision	-	-	$ 675.06K	-	-	-
Earnings From Equity Interest Net Of Tax	$ -9.87K	-	-	-	-	-
Net Income Common Stockholders	$ -2.62M	$ -3.97M	$ -3.52M	$ -5.74M	$ -2.12M	$ -2.59M
Basic EPS	$ -0.03	$ -0.04	$ -0.04	$ -0.22	$ -5.40	$ -7.70
Diluted EPS	$ -0.02	$ -0.04	$ -0.04	$ -0.22	$ -5.40	$ -7.70
Basic Average Shares	$ 535.98M	$ 111.32M	$ 88.35M	$ 25.86M	$ 390.85K	$ 335.11K
Diluted Average Shares	$ 424.66M	$ 111.32M	$ 88.35M	$ 25.86M	$ 390.85K	$ 335.11K
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 3.06M	$ 1.24M	$ 2.11M	$ 3.32M	$ 1.74M	$ 2.18M
Net Income From Continuing And Discontinued Operation	$ -1.87M	$ -2.10M	$ -3.14M	$ -4.30M	$ -2.12M	$ -2.59M
Normalized Income	$ -1.02M	-	-	$ -3.86M	$ -2.14M	$ -2.31M
Interest Expense	$ 94.64K	-	-	$ 545.67K	$ 404.66K	$ 136.24K
EBIT	$ -635.64K	$ -1.50M	$ -2.42M	$ -3.76M	$ -1.71M	$ -2.46M
EBITDA	$ -164.59K	$ -1.11M	$ -1.87M	$ -3.76M	$ -1.71M	$ -2.46M

Currency in USD

RespireRx Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing